Three Low Density Lipoprotein Apheresis Techniques in Treatment of Patients with Familial Hypercholesterolemia: A Long-Term Evaluation

• Published in: Therapeutic apheresis 1999-08, Vol.3 (3), p.203-208
• Main Authors: Richter, Werner O., Donner, Markus G., Schwandt, Peter
• Format: Article
• Language: English
• Subjects: Atherosclerosis; Blood Component Removal - methods; Cholesterol, LDL - isolation & purification; Coronary Angiography; Coronary Disease - complications; Coronary lesions; Dextran Sulfate; Evaluation Studies as Topic; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II - complications; Hyperlipoproteinemia Type II - therapy; Immunosorbent Techniques; Low density lipoprotein apheresis; Male; Middle Aged; Treatment Outcome
• ISSN: 1091-6660; 1526-0968
• DOI: 10.1046/j.1526-0968.1999.00154.x

Low density lipoprotein (LDL) apheresis is a treatment option for patients with severe hypercholesterolemia not adequately responding to drug treatment who have developed coronary heart disease. We regularly treated 18 patients with immunoadsorption, 8 with heparin induced extracorporeal LDL precipitation (HELP) and 8 with dextran sulfate adsorption for a mean of 4.6 ± 2.6 years. The effects on LDL cholesterol, high density lipoprotein (HDL) cholesterol, and lipoprotein (a) were comparable among all 3 techniques. Twelve patients were treated for longer than 5 years and 18 patients for longer than 3 years. The evaluation of coronary angiograms (23 patients) revealed a definite regression of coronary lesions in 3 patients; in all other patients, there was a halt in progression. Three patients suffered a sudden cardiac death and 1 patient a nonfatal myocardial infarction due to the occlusion of a coronary bypass. In 9 of 11 patients, no atherosclerotic lesions developed in the coronary bypasses. No severe side effect of either procedure was observed. In conclusion, aggressive lipid lowering by LDL apheresis can stabilize coronary atherosclerosis in most patients.